ClinVar Genomic variation as it relates to human health
NM_006757.4(TNNT3):c.187C>T (p.Arg63Cys)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_006757.4(TNNT3):c.187C>T (p.Arg63Cys)
Variation ID: 31874 Accession: VCV000031874.17
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 11p15.5 11: 1933736 (GRCh38) [ NCBI UCSC ] 11: 1954966 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 4, 2013 Oct 26, 2024 Oct 12, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_006757.4:c.187C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_006748.1:p.Arg63Cys missense NM_001042780.3:c.163C>T NP_001036245.1:p.Arg55Cys missense NM_001042781.3:c.181C>T NP_001036246.1:p.Arg61Cys missense NM_001042782.3:c.163C>T NP_001036247.1:p.Arg55Cys missense NM_001297646.2:c.163C>T NP_001284575.1:p.Arg55Cys missense NM_001363561.2:c.196C>T NP_001350490.1:p.Arg66Cys missense NM_001367842.1:c.181C>T NP_001354771.1:p.Arg61Cys missense NM_001367843.1:c.181C>T NP_001354772.1:p.Arg61Cys missense NM_001367844.1:c.163C>T NP_001354773.1:p.Arg55Cys missense NM_001367845.1:c.163C>T NP_001354774.1:p.Arg55Cys missense NM_001367846.1:c.220C>T NP_001354775.1:p.Arg74Cys missense NM_001367847.1:c.196C>T NP_001354776.1:p.Arg66Cys missense NM_001367848.1:c.184C>T NP_001354777.1:p.Arg62Cys missense NM_001367849.1:c.175C>T NP_001354778.1:p.Arg59Cys missense NM_001367850.1:c.130C>T NP_001354779.1:p.Arg44Cys missense NM_001367851.1:c.-18C>T 5 prime UTR NM_001367852.1:c.-18C>T 5 prime UTR NC_000011.10:g.1933736C>T NC_000011.9:g.1954966C>T LRG_850t1:c.187C>T LRG_850p1:p.Arg63Cys - Protein change
- R63C, R62C, R66C, R44C, R55C, R61C, R74C, R59C
- Other names
-
p.Arg63Cys
- Canonical SPDI
- NC_000011.10:1933735:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
-
functional variant; Sequence Ontology [ SO:0001536]
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
TNNT3 | - | - |
GRCh38 GRCh38 GRCh37 |
246 | 287 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (2) |
criteria provided, single submitter
|
Dec 10, 2021 | RCV000024570.7 | |
Pathogenic (1) |
criteria provided, single submitter
|
Jul 1, 2015 | RCV000194279.6 | |
Likely pathogenic (6) |
criteria provided, multiple submitters, no conflicts
|
Oct 12, 2023 | RCV000787280.7 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely pathogenic
(Aug 22, 2019)
|
criteria provided, single submitter
Method: curation
|
Arthrogryposis, distal, type 2B2
Affected status: unknown
Allele origin:
unknown
|
SIB Swiss Institute of Bioinformatics
Accession: SCV000996474.1
First in ClinVar: Nov 02, 2019 Last updated: Nov 02, 2019 |
Comment:
This variant is interpreted as a Likely pathogenic for Arthrogryposis, distal, 2B2, autosomal dominant. The following ACMG Tag(s) were applied: PM2, PP3, PP1, PM5.
|
|
Likely pathogenic
(Dec 15, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Arthrogryposis, distal, type 2B2
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
germline
|
Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics
Accession: SCV002817385.1
First in ClinVar: Feb 07, 2023 Last updated: Feb 07, 2023 |
Comment:
A heterozygous missense variation in exon 10 of the TNNT3 gene that results in the amino acid substitution of Cysteine for Arginine at codon 63 … (more)
A heterozygous missense variation in exon 10 of the TNNT3 gene that results in the amino acid substitution of Cysteine for Arginine at codon 63 (p.Arg63Cys) was detected . The observed variation has previously been reported in patients affected with distal arthrogryposis [PMID:21402185]. This variant has not been reported in the 1000 genomes, gnomAD databases. The in silico predictions of the variant are probably damaging by PolyPhen-2 (HumDiv) and damaging by SIFT, LRT and MutationTaster2. The reference codon is conserved across mammals. In summary, the variant meets our criteria to be classified as likely pathogenic. (less)
Clinical Features:
Microcephaly (present) , Generalized hypotonia (present) , Long philtrum (present) , Atrial septal defect (present) , Inguinal hernia (present) , Premature birth (present) , Flexion … (more)
Microcephaly (present) , Generalized hypotonia (present) , Long philtrum (present) , Atrial septal defect (present) , Inguinal hernia (present) , Premature birth (present) , Flexion contracture (present) , Small for gestational age (present) , Hypertelorism (present) , Growth delay (present) (less)
Age: 0-9 years
Sex: male
Method: DNA was used to perform targeted gene capture using a custom capture kit. Libraries were sequenced to mean >80-100X coverage on the Illumina sequencing platform. Sequence obtained were aligned to human references genome using BWA program and analyzed using Picard and GATK-Lite toolkit to identify variants in the targeted genes relevant to clinical indication.
|
|
Pathogenic
(Dec 10, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV001813516.3
First in ClinVar: Sep 08, 2021 Last updated: Mar 04, 2023 |
Comment:
Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This … (more)
Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 31230720, 23401156, 21402185, 26774798, 34766372, 33977145) (less)
|
|
Pathogenic
(Jul 01, 2015)
|
criteria provided, single submitter
Method: clinical testing
|
Arthyrgryposis, distal, type 2B
Affected status: yes
Allele origin:
germline
|
Genetic Services Laboratory, University of Chicago
Accession: SCV000249170.1
First in ClinVar: Oct 05, 2015 Last updated: Oct 05, 2015 |
|
|
Likely pathogenic
(Oct 12, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Arthrogryposis, distal, type 2B2
Affected status: yes
Allele origin:
germline
|
Institute of Immunology and Genetics Kaiserslautern
Accession: SCV005382212.1
First in ClinVar: Oct 26, 2024 Last updated: Oct 26, 2024 |
Comment:
ACMG Criteria: PM2, PM5, PP3, PP5; Variant was found in heterozygous state.
Clinical Features:
Global developmental delay (present) , Microcephaly (present) , Flexion contracture of digit (present) , Short stature (present) , Pes planus (present)
|
|
Pathogenic
(May 01, 2011)
|
no assertion criteria provided
Method: literature only
|
ARTHROGRYPOSIS, DISTAL, TYPE 2B2
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000914181.1
First in ClinVar: May 20, 2019 Last updated: May 20, 2019 |
Comment on evidence:
In all 5 affected members of a Chinese family segregating (DA2B2; 618435) mapped to chromosome 11p15, Zhao et al. (2011) identified heterozygosity for a missense … (more)
In all 5 affected members of a Chinese family segregating (DA2B2; 618435) mapped to chromosome 11p15, Zhao et al. (2011) identified heterozygosity for a missense mutation (R63C; 600692.0002) in the TNNT3 gene. The mutation, which occurred at the same codon previously reported in patients with DA2B2 (600692.0001), was not found in an unaffected member of the family or in 100 controls. (less)
|
|
Pathogenic
(May 03, 2019)
|
no assertion criteria provided
Method: clinical testing
|
Arthrogryposis, distal, type 2B2
Affected status: yes
Allele origin:
de novo
|
Oxford Medical Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust
Accession: SCV000926212.1
First in ClinVar: Jul 14, 2019 Last updated: Jul 14, 2019 |
|
|
Uncertain significance
(-)
|
no assertion criteria provided
Method: research
|
Arthrogryposis, distal, type 2B2
This variant was identified in an
(more...)
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
unknown
|
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine
Accession: SCV001167516.1
First in ClinVar: Mar 16, 2020 Last updated: Mar 16, 2020 |
Number of individuals with the variant: 1
|
|
not provided
(Mar 18, 2012)
|
no classification provided
Method: curation
|
not specified
Affected status: not provided
Allele origin:
germline
|
Leiden Muscular Dystrophy (TNNT3)
Accession: SCV000045874.1
First in ClinVar: Apr 04, 2013 Last updated: Apr 04, 2013 |
|
Germline Functional Evidence
Functional
Help
The functional consequence of the variant, based on experimental evidence and provided by the submitter. consequence |
Method
Help
A brief description of the method used to determine the functional consequence of the variant. A citation for the method is included, when provided by the submitter. |
Result
Help
A brief description of the result of this method for this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting functional evidence for the germline classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
---|---|---|---|---|
has functional consequence
|
Leiden Muscular Dystrophy (TNNT3)
Accession: SCV000045874.1
|
|
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
A novel mutation in TNNT3 associated with Sheldon-Hall syndrome in a Chinese family with vertical talus. | Zhao N | European journal of medical genetics | 2011 | PMID: 21402185 |
Text-mined citations for rs199474721 ...
HelpRecord last updated Nov 03, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.